synDNA vaccine against TCR chains and neoantigens for T cell lymphoma therapy.

Cancer Immunol Immunother · 2026 · PMC12906415 · PMID 41689634

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep value = 0.08so close (0.05 < p ≤ 0.1)

While there was a trend in improvement of survival in vaccinated animals (median survival 25 days vs 22 days), this did not reach statistical significance ( p value = 0.08) (Fig. 4 D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.